Psychopharmacology and Neurotherapeutics

Drs. Gabrielle and Harold Carlson Psychopharmacology Research Award

This newly available award offers $20,000 ($10,00 per year) to one child and adolescent psychiatry 2^nd year fellow or early career faculty annually to complete a two-year mentored research project in the area of psychopharmacology and/or neurotherapeutics, with a focus on practical and investigative work toward treatment for children and adolescents.

Policy Statements

Products

Parents’ Medication Guides

AACAP and the American Psychiatric Association (APA) have developed Parents’ Medication Guides to help individuals make informed decisions about treating mental disorders in children and adolescents.

Clinical Toolbox

The Toolbox was developed as a resource for AACAP members who may find it useful in assessing and monitoring care in some cases in their practice. It gives members immediate access to free downloadable instruments for use in clinical practice. The Toolbox is under review and will be updated in 2024.

Facts For Families

Clinical Essentials: A Series of Online CME Courses

These self-study courses feature high quality, clinically relevant content and address individual’s educational needs by incorporating elements of microlearning. Learners can deepen their knowledge on these important topics by viewing highly rated videos and lectures from top rated AACAP speakers and completing a post-test. Click on the course to purchase.

NEW!
Catatonia

Earn up to 4.25 AMA PRA Category 1 CME Credits™
Learn more

AACAP News Articles

Introducing the 2024 Parent’s Medication Guide to Bipolar Disorder and How to Talk to Parents about Mood Stabilizers (2025) by Adelaide Robb, MD, Charles Whitmore, MD, MPH, Ekaterina Stepanova, MD, PhD, Robert Findling, MD, MBA, Ritvij Satodiya, MD, Raman Baweja, MD, MS
Child Psychiatrists’ Perspectives on Psychedelics in Research and Practice (2024) by Scott Aaronson, MD, Raman Baweja, MD, MS, Paul E. Croarkin, DO, MS, Boris Lorberg, MD, MBA
Updates on Catatonia in Children and Adolescents (2023) by Boris Lorberg, MD, MBA, Raman Baweja, MD, MS, Eric Hazen, MD, and Robyn Thom, MD
What is New in Substance Abuse Treatment? Nasal Naloxone is Available Without a Prescription (2023) by Sara Polley, MD, and Boris Lorberg, MD
Issues of Different Generic vs. Brand Medications and Their Shortages (2023) by Boris Lorberg, MD, and Petronella Mbu, MD
The Birth of an “Impairing Emotional Outbursts” R Code (2022) by Boris Lorberg, MD, Petronella Mbu, MD, and Gabrielle Carlson, MD
ADHD Updates – What Can We Learn from the Expert? (2022) by Colin Whitworth, MD, Boris Lorberg, MD, and Jeffrey H. Newcorn, MD
Toxicology Testing for Children, Adolescents, and Emerging Adults (CAEAs) Undergoing Treatment with Controlled Substances (2022) by Tatjana Josic, DO, Raman Baweja, MD, MS, Scott Krakower, DO, DFAACAP, and Patrice K. Malone, MD, PhD
Ketamine Treatment of Pediatric Depression – What Can We Learn From the Experts? (2021) by Joshua Kriegel, MD, Boris Lorberg, MD, Michael Bloch, MD, and Jennifer Dwyer, MD, PhD

Pediatric Psychopharmacology Update Institutes

2024 Advanced Pediatric Psychopharmacology: What to Do Next When Treatments Don't Work
Co-Chairs: Boris Birmaher, MD, and Adelaide S. Robb, MD
2023 Impulsive Aggression Across Diagnoses
Co-Chairs: Jeffrey R. Strawn, MD, and Jean A. Frazier, MD
2022 Virtual Pediatric Psychopharmacology Update Institute: Working Hands-On With Master Clinicians
Co-Chairs: Gabrielle A. Carlson, MD, and James J. McGough, MD
2021 Virtual Pediatric Psychopharmacology Update Institute: Beyond One Size Fits All: Predicting Medication Response
Co-Chairs: Gabrielle A. Carlson, MD, and Jeffrey R. Strawn, MD
2020 Translating Advances in Pediatric Psychopharmacology into Practice: Molecules, Mechanisms, and Medications
Co-Chairs: James J. McGough, MD and Manpreet Kaur Singh, MD, MS
2019 Early Treatment Intervention: When, What, and For How Long?
Co-Chairs: Boris Birmaher, MD, and Gabrielle A. Carlson, MD